Literature DB >> 29355853

Microbiome: Gut microbiota sways response to cancer immunotherapy.

Ashley York.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29355853     DOI： 10.1038/nrmicro.2018.12

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN： 1740-1526            Impact factor:   60.633


× No keyword cloud information.
  3 in total

1.  The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.

Authors:  Vyara Matson; Jessica Fessler; Riyue Bao; Tara Chongsuwat; Yuanyuan Zha; Maria-Luisa Alegre; Jason J Luke; Thomas F Gajewski
Journal:  Science       Date:  2018-01-05       Impact factor: 47.728

2.  Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Authors:  V Gopalakrishnan; C N Spencer; L Nezi; A Reuben; M C Andrews; T V Karpinets; P A Prieto; D Vicente; K Hoffman; S C Wei; A P Cogdill; L Zhao; C W Hudgens; D S Hutchinson; T Manzo; M Petaccia de Macedo; T Cotechini; T Kumar; W S Chen; S M Reddy; R Szczepaniak Sloane; J Galloway-Pena; H Jiang; P L Chen; E J Shpall; K Rezvani; A M Alousi; R F Chemaly; S Shelburne; L M Vence; P C Okhuysen; V B Jensen; A G Swennes; F McAllister; E Marcelo Riquelme Sanchez; Y Zhang; E Le Chatelier; L Zitvogel; N Pons; J L Austin-Breneman; L E Haydu; E M Burton; J M Gardner; E Sirmans; J Hu; A J Lazar; T Tsujikawa; A Diab; H Tawbi; I C Glitza; W J Hwu; S P Patel; S E Woodman; R N Amaria; M A Davies; J E Gershenwald; P Hwu; J E Lee; J Zhang; L M Coussens; Z A Cooper; P A Futreal; C R Daniel; N J Ajami; J F Petrosino; M T Tetzlaff; P Sharma; J P Allison; R R Jenq; J A Wargo
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

3.  Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Authors:  Bertrand Routy; Emmanuelle Le Chatelier; Lisa Derosa; Connie P M Duong; Maryam Tidjani Alou; Romain Daillère; Aurélie Fluckiger; Meriem Messaoudene; Conrad Rauber; Maria P Roberti; Marine Fidelle; Caroline Flament; Vichnou Poirier-Colame; Paule Opolon; Christophe Klein; Kristina Iribarren; Laura Mondragón; Nicolas Jacquelot; Bo Qu; Gladys Ferrere; Céline Clémenson; Laura Mezquita; Jordi Remon Masip; Charles Naltet; Solenn Brosseau; Coureche Kaderbhai; Corentin Richard; Hira Rizvi; Florence Levenez; Nathalie Galleron; Benoit Quinquis; Nicolas Pons; Bernhard Ryffel; Véronique Minard-Colin; Patrick Gonin; Jean-Charles Soria; Eric Deutsch; Yohann Loriot; François Ghiringhelli; Gérard Zalcman; François Goldwasser; Bernard Escudier; Matthew D Hellmann; Alexander Eggermont; Didier Raoult; Laurence Albiges; Guido Kroemer; Laurence Zitvogel
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728
  3 in total
  12 in total

1.  Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.

Authors:  Dae Hee Pyo; Hye Kyung Hong; Woo Yong Lee; Yong Beom Cho
Journal:  Cancer Biol Ther       Date:  2020-03-25       Impact factor: 4.742

Review 2.  Targeting the IDO1 pathway in cancer: from bench to bedside.

Authors:  Ming Liu; Xu Wang; Lei Wang; Xiaodong Ma; Zhaojian Gong; Shanshan Zhang; Yong Li
Journal:  J Hematol Oncol       Date:  2018-08-02       Impact factor: 17.388

Review 3.  The Microbiome and Its Implications in Cancer Immunotherapy.

Authors:  Hani Choudhry
Journal:  Molecules       Date:  2021-01-03       Impact factor: 4.411

Review 4.  Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy.

Authors:  Yilun Liu; Zhongmin Li; Yuanyu Wu; Xiabin Jing; Lin Li; Xuedong Fang
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

Review 5.  Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives.

Authors:  Florent Peyraud; Jean-Philippe Guegan; Dominique Bodet; Sophie Cousin; Alban Bessede; Antoine Italiano
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

6.  Specific properties of probiotic strains: relevance and benefits for the host.

Authors:  Rostyslav V Bubnov; Lidiia P Babenko; Liudmyla M Lazarenko; Victoria V Mokrozub; Mykola Ya Spivak
Journal:  EPMA J       Date:  2018-04-13       Impact factor: 6.543

Review 7.  Consideration of Gut Microbiome in Murine Models of Diseases.

Authors:  Chunye Zhang; Craig L Franklin; Aaron C Ericsson
Journal:  Microorganisms       Date:  2021-05-14

Review 8.  Novel Delivery Systems for Checkpoint Inhibitors.

Authors:  Purushottam Lamichhane; Rahul Deshmukh; Julie A Brown; Silvia Jakubski; Priyanka Parajuli; Todd Nolan; Dewan Raja; Mary Badawy; Thomas Yoon; Mark Zmiyiwsky; Narottam Lamichhane
Journal:  Medicines (Basel)       Date:  2019-07-11

Review 9.  The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer.

Authors:  Rossella Cianci; Laura Franza; Giovanni Schinzari; Ernesto Rossi; Gianluca Ianiro; Giampaolo Tortora; Antonio Gasbarrini; Giovanni Gambassi; Giovanni Cammarota
Journal:  Int J Mol Sci       Date:  2019-01-24       Impact factor: 5.923

10.  Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth.

Authors:  Yan Li; Lisa Elmén; Igor Segota; Yibo Xian; Roberto Tinoco; Yongmei Feng; Yu Fujita; Rafael R Segura Muñoz; Robert Schmaltz; Linda M Bradley; Amanda Ramer-Tait; Raphy Zarecki; Tao Long; Scott N Peterson; Ze'ev A Ronai
Journal:  Cell Rep       Date:  2020-02-11       Impact factor: 9.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.